Amgen's postmenopausal osteoporosis drug gets FDA approval

The U.S. Food and Drug Administration said on Tuesday it had approved Amgen Inc's osteoporosis treatment for postmenopausal women at high risk of fracture.

from Reuters: Health News https://reut.rs/2GbM2HK
via IFTTT